摘要 |
This invention provides compounds having the structure (I) wherein R<SUB>1</SUB> is methyl and R<SUB>2</SUB> is H, or R<SUB>1</SUB> is ethyl and R<SUB>2</SUB> is hydroxymethyl; R<SUB>3</SUB> is H or propargyl; and R<SUB>4</SUB> is either H or t-butyloxycarbonyl; or an enantiomer or a pharmaceutically acceptable salt thereof. This invention further provides the use of a therapeutically effective amount of such compounds to treat a subject afflicted with a psychiatric disorder, Parkinson's disease, Alzheimer's disease, dementia, or a neurological disorder. |
申请人 |
TEVA PHARMACEUTICAL INDUSTRIES, LTD.;TEVA PHARMACEUTICALS USA, INC. |
发明人 |
PIRYATINSKY, VICTOR;COHEN, BRONKA;LERNER, DAVID;PINKERT, DALIA;MISKOLCZI, ISTVAN;HERZIG, YAACOV;GOTTLIEB, HUGO |